Latest Angioslide Ltd. Stories

NATANYA, Israel, January 3, 2013 /PRNewswire/ -- Angioslide, a provider of Embolic Capture Angioplasty solutions, announced today the closing of $6.3 million financing led by new investor TriVentures. In addition Biostar joined returning investors Viola Partners, Agate and XT Investments (formerly Ofer HT) to complete the round. "Proceeds from this Series C round will be used to continue US market expansion, improve our product offering and validate the technology in...

CAESAREA, Israel, July 11, 2012 /PRNewswire/ -- Angioslide Ltd., a provider of Embolic Capture Angioplasty solutions, today announced the successful deployment of a 3X100mm PROTEUS device for treating Peripheral Artery Disease in below-the-knee (BTK) vasculature at Community Hospital in Munster, IN. Accommodating a 0.014" guide-wire, the new device allows physician to perform a PTA revascularization in BTK vessels while capturing and removing embolic particles. "With...

CAESAREA, Israel, May 2, 2012 /PRNewswire/ -- Angioslide Ltd. a provider of Embolic Capture Angioplasty solutions, today announced that it has received FDA 510(K) clearance for its new 3X100mm PROTEUS device for treating Peripheral Artery Disease in below the knee (BTK) vasculature. The new 3/100mm device accommodates 0.014" guide-wires, which significantly broadens the potential use of PROTEUS technology. Angioslide's proprietary technology combines the functionality...

CAESAREA, Israel, November 7, 2011 /PRNewswire/ -- Angioslide, a provider of Embolic Capture Angioplasty solutions, announced today that it has been named one of Israel's top ten most promising startups of 2011. The award was presented to Angioslide during the Ernst & Young (E&Y) Journey 2011 conference, held in Tel Aviv - one of Israel's leading technology conferences, featuring prominent technology, healthcare and cleantech companies. "We are proud and honored...

CAESAREA, Israel, September 8, 2011 /PRNewswire/ -- Angioslide Ltd. announces the first procedures with its new 5x300mm PROTEUS device for treating the Superficial Femoral Artery (SFA). PROTEUS technology combines a Percutaneous Transluminal Angioplasty (PTA) balloon and embolic capture of particles in one device. The new 5x300 mm size joins Angioslide's current dedicated product line solutions for the lower limbs. Initial treatments using the new PROTEUS device were...

MINNEAPOLIS, Minnesota, September 15, 2010 /PRNewswire/ -- Angioslide, Inc. of Minneapolis, MN and Angioslide, Ltd. Herzliya, Israel, announced today that the company has commercialized the Proteus device for Embolic Capture Angioplasty (ECA) in the United States. The device combines an angioplasty balloon and embolic capture feature into one device, thus providing physicians with a simple and cost-effective method of capturing of embolic particles during angioplasty procedures. Proteus...